データを補完しています。しばらくしてからページを更新すると最新の内容を表示できます
23205-42-7O=C1C=CN([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(=O)C1WIRVQQCUKDPURA-PEBGCTIMSA-N23205-42-7、39935-49-4DTXSID801036264安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
説明3-Deazauridine is a structural analog of uridine that inhibits the biosynthesis of Cytidine-5'-Triphosphate by competitive inhibition of Cytidine Triphosphate synthetase, which is considered to be the primary mode of action of this nucleoside analog. This compound has been shown to possess in vitro activity against leukemia L1210 tumor cells, Ehrlich ascites tumor cells, Escherichia coli, and Streptococcus faecium. Despite a paucity of clinical attention given to this drug as a single agent, it has generated much enthusiasm as a biological response modulator because of its synergistic effect with several antitumor agents, including Cytosine Arabinoside, 5-aza-2'-deoxycytidine, 5-azacytidine, thymidine and D-galactosamine. However, only the cytosine arabinoside/3-Deazauridine combination has been explored clinically[1-2].
使用Antimetabolite antiviral dosing regimen for hepatitis C virus or flaviviridae therapy.
現在のフィルター条件では反応記録がありません。
読み込み中…